Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04084717
Title Study of Crizotinib for ROS1 and MET Activated Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications

lung non-squamous non-small cell carcinoma

Therapies

Crizotinib

Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST